🔎 Trials Near Me

Home › Smoking and Youth › NCT07459621

Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking

Recruiting

Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking: A Randomized Controlled Trial

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* 18 years of age and older
* Current cigarette smoker who is ambivalent about smoking
* Not actively using any treatment to quit smoking
* Own and regularly use a smartphone
* State willingness to install and use their assigned app
* Willingness to receive study communications
* Smoke at least half a pack a day
* Meet geolocation requirements

Exclusion Criteria:

* A lifetime history of dementia or psychosis
* Visual impairments that prevent viewing phone content and they lack adaptive devices
* Report medical contra-indications for over-the-counter NRT use
* Due to the potential for bias introduced by fraudulent participants, other exclusions will be applied to deter fraudulent enrollment.

About the study

The goal of this study is to compare the effectiveness of two smoking cessation programs to determine which better helps people change their smoking behavior, the control or the experimental intervention? Both interventions include access to a mHealth app and other publicly available stop-smoking resources. The two app versions each include best practice advice and guidance for quitting smoking, but one includes additional content designed for people who aren't ready to quit smoking.

The investigators hypothesize that people who receive the experimental intervention will be more likely to request additional stop-smoking resources offered through the intervention and report smoking abstinence after 6 months.

The investigators also hypothesize people assigned to the experimental app will have better app engagement and be more likely to report positive changes in their smoking behavior and use of other evidence-based stop smoking treatments that are publicly available.

What is being tested

Sponsor: Kaiser Permanente · Participants: 800 · Started: Apr 7, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07459621

Locations in the U.S.

OregonKaiser Permanente Center for Health Research, Portland

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.